investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Andrew A Lane

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Nora C Heisterkamp

Role of Sialic Acid Modification in ALL Survival and Drug Resistance

Leukaemia

Pathology Hematology and hematologic malignancies

Kapil Bhalla

Novel Targeted Therapy for AML

Leukaemia

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Ronen Marmorstein

Structure and Function of Protein Acetyltransferases

Leukaemia

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia

Catherine Ju-Ying Wu

The role of the SF3B1 splicing factor in chronic lymphocytic leukemia

Leukaemia

Zbigniew Darzynkiewicz

Probes for Cytometry

Leukaemia

Radiation Oncology Hematology and hematologic malignancies

Peng Huang

Novel Strategies to Target Leukemia-Stromal Interactions

Leukaemia

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Leukaemia